Tuesday, August 02, 2022 5:06:46 PM
Revs under $300K will help confirm the huge miss that this will experience with its projected $5M '22 revenues.
What a shame for a Co. that had tremendous potential with their product at the height of one of the worst pandemics in recent history.
Some here will spin the resurgence of Covid and the Monkey Pox as another supposed windfall. This Co. shit in their hat the first go around and there's absolutely nothing that's improved other than a few new faces that will make round two any different.
Oh wait! Test number 98-456QW-56/000009 rev. 2 will be out any day from the grassy knoll. That will make up the difference and put them at the $5M mark.
Recent PCTL News
- Form 8-K - Current report • Edgar (US Regulatory) • 10/05/2023 02:05:09 PM
- Form 15-12G/A - Securities registration termination [Section 12(g)]: [Amend] • Edgar (US Regulatory) • 07/18/2023 07:06:52 PM
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 07/13/2023 04:32:57 PM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM